Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Verapamil in Dravet Syndrome
NCT01607073Phase 2Completed
- Sponsor
- Gillette Children's Specialty Healthcare
- Start
- Apr 2012
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of verapamil in Dravet syndrome, sponsored by Gillette Children's Specialty Healthcare. Started Apr 2012; status: completed.
02
Drugs
verapamil
03
Conditions
Dravet syndrome
Beyond the preview
Go deeper on NCT01607073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01607073.